Paradigm Biopharmaceuticals Limited (ASX:PAR)
0.3350
+0.0050 (1.52%)
At close: Jan 16, 2026
-20.24% (1Y)
| Market Cap | 143.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -18.77M |
| Shares Out | 428.52M |
| EPS (ttm) | -0.06 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 604,008 |
| Average Volume | 861,036 |
| Open | 0.3350 |
| Previous Close | 0.3300 |
| Day's Range | 0.3300 - 0.3350 |
| 52-Week Range | 0.2550 - 0.6600 |
| Beta | 0.30 |
| RSI | 48.11 |
| Earnings Date | Feb 25, 2026 |